LOSE WEIGHT

Sunday, January 28, 2018

MESOTHELIOMA CANCER

Lung cancer patients, mesothelioma patients and oncologists are closely following a Phase II clinical trial after researchers reported “unprecedented response rates” in lung cancer patients. All of the patients who were treated with a previously abandoned drug showed some tumor shrinkage.
A team of researchers from the Moon Shots program at MD Anderson Cancer Center were looking for a way to treat patients with the epidermal growth factor receptor (EGFR) mutation called an exon 20 insertion. Referred to as a “harsh” or treatment-resistant mutation, it is extremely challenging, if not impossible, to treat in non-small cell lung cancer patients.
The team turned to poziotinib, an investigational oncology drug from Spectrum Pharmaceuticals, a U.S. based biotechnology company with a core mission to bring pharmaceutical products to patients for unmet medical needs. Although, according to the researchers, poziotinib “had been tried and abandoned as a general EGFR inhibitor against lung cancer,” they looked twice after a drug-screening program pointed to it.
In the study of 11 non-small cell lung cancer patients who expressed EGFR exon 20 insertion treated with poziotinib, all patients experienced some tumor shrinkage. Eight of the 11 patients saw their tumors shrink by at least 30 percent. The shrinkage ranged from 30 percent to 50 percent among the eight patients reaching partial response.  The trial began in March and is scheduled to run through March 2021. The goal is to recruit 80 patients.
“These early results are highly encouraging, and our research shows that poziotinib’s structure makes it a great potential fit for attacking this mutation,” said clinical trial leader John Heymach, M.D., Ph.D., chair of Thoracic/Head and Neck Medical Oncology at MD Anderson and holder of the David Bruton Junior Chair in Cancer Research in an Oct. 17 press release.
The EGFR gene has been the focus of researchers for finding new, effective treatments for both lung cancer and mesothelioma patients. The gene, that is overexpressed in more than 50% of pleural mesothelioma patients, and in approximately 15% of lung cancer patients, is one of the primary targets for bringing personalized care to the cancer patients. About two percent, or 3,500 annually in the U.S., of non-small cell lung cancer patients have an EGFR exon 20 insertion.
Patients with pleural mesothelioma, an asbestos-caused cancer that infects the lining of the lungs, often undergo a treatment protocol the same as lung cancer patients. The move to targeted medicine, where oncologists check for genetic biomarkers like the EGFR exon 20 insertion, often drives the selection of the drug more than the cancer itself. Research like this is critical for extending the survival of mesothelioma, an incurable cancer. See here for information on the first drug approved by the FDA based on a biomarker and not the cancer type.
Rajesh C. Shrotriya, M.D., Spectrum Pharmaceuticals
Expert Insight
“We are greatly encouraged with the clinical data emerging from poziotinib and plan to pursue its clinical development expeditiously and aggressively.”
This research is being funded by the Lung Cancer Moon Shots Program. Preliminary results were presented at the International Association for the Study of Lung Cancer 18th World Conference on Lung Cancer in Yokohama, Japan in October.
The Moon Shots Program, launched in Sept. 2012, was undertaken “to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.” According to the website, “the Lung Cancer Moon Shot team, led by Dr. Heymech, is revolutionizing the conventional medical research approach to rapidly adapt pre-clinical findings into lung cancer treatment options.”
“To date poziotinib has shown promising results in patients with exon 20 insertion mutations and we are fortunate to be leading the efforts in the continuing development of this product,” said Dr. Heymech.
To find out more about the trial see ClinicalTrials.gov.

Tuesday, November 28, 2017

MESOTHELIOMA CANCER INFORMATION

Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the internal organs (known as the mesothelium). The most common area affected is the lining of the lungs and chest wall.











Sunday, August 3, 2014

Source For Free Weight Loss Information  on diet and fat loss questions, including: how to reduce weight, how to burn body fat, how fast to lose weight, how to reduce fat on thighs, what is overweight and obesity, how to lower cholesterol, how to raise metabolism, how to cut calories, how to control weight during/after pregnancy or during menopause are diet pills safe, what's involved in gastric bypass or other types ofbariatric weight loss surgery, diet nutrition, weight loss tips, and much much more.
Also included are reviews of a huge variety of diets including all popular fad diets. There are also a large number of facts on carbs, Glycemic Index information and GI diets, fat loss supplements, patches, recipes for rapid weight loss, clinics & obesity support groups. Information about the calories in food as well as the levels of cholesterol in food is also available on the site.
All of the information and diet plans on this website are free so please make sure to bookmark this site so that you can return any time you need to find out answers to your weight loss and diet questions.

Free Diet Plans

Our diet plans have helped many thousands of people to successfully lose weight over the years. There are nine different weight loss plans for you to choose from so try any, or all, of them until you find the one that works best for you. Follow this link to check out the nine diet programs.
This is a fantastic opportunity that I won't be repeating any time soon. Make sure to tell your friends and family about this unique opportunity.

Source For Free Weight Loss Information  on diet and fat loss questions, including: how to reduce weight, how to burn body fat, how fast to lose weight, how to reduce fat on thighs, what is overweight and obesity, how to lower cholesterol, how to raise metabolism, how to cut calories, how to control weight during/after pregnancy or during menopause are diet pills safe, what's involved in gastric bypass or other types ofbariatric weight loss surgery, diet nutrition, weight loss tips, and much much more.
Also included are reviews of a huge variety of diets including all popular fad diets. There are also a large number of facts on carbs, Glycemic Index information and GI diets, fat loss supplements, patches, recipes for rapid weight loss, clinics & obesity support groups. Information about the calories in food as well as the levels of cholesterol in food is also available on the site.
All of the information and diet plans on this website are free so please make sure to bookmark this site so that you can return any time you need to find out answers to your weight loss and diet questions.

                                           
                                                 




OBESITY, OVERWEIGHT and HEALTH

WEIGHT CONTROL
Weight Loss Tips | Best Support Group | Easy Ways to Lose Weight | Lose Last 10 Pounds | Nutrition and Pregnancy Lose Weight After Pregnancy | Weight Loss - Pregnancy | Mid-Life Weight Gain | Weight Control in Menopause Menopause & Diet | Weight and Depression | Teen Weight Loss & Healthy Eating | Help For Overweight Children Child Obesity | Weight Chart For Children | Weight Loss For Men | Fast Weight Loss | Raise Metabolism Best Exercise to Burn Calories | Exercise and Calories Burned | Diet Pills | Weight Loss Drugs to Reduce Obesity  Bariatric Surgery | Gastrointestinal Surgery | Health Dangers of Bariatric Surgery | Health Dangers of Gastric Bypass Weight Loss Programs | Articles | Weight Loss Questions | How to Reduce Weight | Weight Loss Advice

DIETING and DIETARY ADVICE
ENERGY and NUTRITIONAL INFORMATION



Main Pages



Channels


Slim Down Diet & Fast Slim 
Weight Loss Diets

TheHcgDiet.ca, Nutritionist and Top Weight Loss Information